These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 12719202)

  • 21. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The costs of cancer to a major employer in the United States: a case-control analysis.
    Barnett A; Birnbaum H; Cremieux PY; Fendrick AM; Slavin M
    Am J Manag Care; 2000 Nov; 6(11):1243-51. PubMed ID: 11185849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional dyspepsia impacts absenteeism and direct and indirect costs.
    Brook RA; Kleinman NL; Choung RS; Melkonian AK; Smeeding JE; Talley NJ
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):498-503. PubMed ID: 20304102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct and indirect costs associated with Dupuytren's contracture.
    Macaulay D; Ivanova J; Birnbaum H; Sorg R; Skodny P
    J Med Econ; 2012; 15(4):664-71. PubMed ID: 22369346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irritable bowel syndrome: toward a cost-effective management approach.
    Martin R; Barron JJ; Zacker C
    Am J Manag Care; 2001 Jul; 7(8 Suppl):S268-75. PubMed ID: 11474912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costs of asthma among US working adults.
    Shenolikar R; Song X; Anderson JA; Chu BC; Cantrell CR
    Am J Manag Care; 2011 Jun; 17(6):409-16. PubMed ID: 21756011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impairment in work productivity and health-related quality of life in patients with IBS.
    Dean BB; Aguilar D; Barghout V; Kahler KH; Frech F; Groves D; Ofman JJ
    Am J Manag Care; 2005 Apr; 11(1 Suppl):S17-26. PubMed ID: 15926760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct cost burden among insured US employees with migraine.
    Hawkins K; Wang S; Rupnow M
    Headache; 2008 Apr; 48(4):553-63. PubMed ID: 18070057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attention-deficit/hyperactivity disorder: increased costs for patients and their families.
    Swensen AR; Birnbaum HG; Secnik K; Marynchenko M; Greenberg P; Claxton A
    J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1415-23. PubMed ID: 14627876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Budget impact of tegaserod on a managed care organization formulary.
    Bloom MA; Barghout V; Kahler KH; Bentkover J; Kurth H; Gralnek IM; Spiegel BM
    Am J Manag Care; 2005 Apr; 11(1 Suppl):S27-34. PubMed ID: 15926761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently.
    Robinson RL; Birnbaum HG; Morley MA; Sisitsky T; Greenberg PE; Wolfe F
    J Rheumatol; 2004 Aug; 31(8):1621-9. PubMed ID: 15290744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower respiratory tract infections: impact on the workplace.
    Birnbaum H; Morley M; Leong S; Greenberg P; Colice G
    Pharmacoeconomics; 2003; 21(10):749-59. PubMed ID: 12828496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct and indirect costs attributable to osteoarthritis in active subjects.
    Rabenda V; Manette C; Lemmens R; Mariani AM; Struvay N; Reginster JY
    J Rheumatol; 2006 Jun; 33(6):1152-8. PubMed ID: 16755664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study.
    Lajas C; Abasolo L; Bellajdel B; Hernández-García C; Carmona L; Vargas E; Lázaro P; Jover JA
    Arthritis Rheum; 2003 Feb; 49(1):64-70. PubMed ID: 12579595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US.
    Ivanova JI; Birnbaum HG; Samuels S; Davis M; Phillips AL; Meletiche D
    Pharmacoeconomics; 2009; 27(8):681-91. PubMed ID: 19712010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective.
    Lamb CE; Ratner PH; Johnson CE; Ambegaonkar AJ; Joshi AV; Day D; Sampson N; Eng B
    Curr Med Res Opin; 2006 Jun; 22(6):1203-10. PubMed ID: 16846553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costs of physical and mental comorbidities among employees: a comparison of those with and without bipolar disorder.
    Rajagopalan K; Kleinman NL; Brook RA; Gardner HH; Brizee TJ; Smeeding JE
    Curr Med Res Opin; 2006 Mar; 22(3):443-52. PubMed ID: 16574028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.